In this manuscript, the authors identified that Fis1 interacts with STX17. Then, they found that overexpression of STX17 in Fis1 KO/KD cells induce mitophagy. They further studied the specific domain required for Fis1-STX17 interaction and the role of the domains on mitophagy. As previously reported, they showed that STX17 interacts with Atg14 and localizes on MAM. As expected again, they showed that most of conventional autophagy factors are related with STX17 induced mitophagy in Fis1KO cells. Although there shown large number of experimental results in this paper, each experiments are not well performed to confirm their conclusion. Especially, the observation of mitophagy is not well performed. Most importantly, overexpression of STX17 in Fis1 KO/KD is not physiological situation. This reviewer thinks that the mitophagy induction used in this paper is too artificial and it is not reflects phenomena in vivo. The authors should consider the following:
The data in this study are very interesting and could provide new insights into the molecular mechanisms of mitophagy in mammalian cells. However, there is no evidence suggesting that STX17 can promote mitophagy in wild-type cells under physiological conditions (without any genetic manipulations). For example, are there any cell types expressing (and/or culture conditions leading to) low and high levels of Fis1 and STX17, respectively? This manuscript would be significantly strengthened if the authors address this major issue and the following points.
Specific points:
1. In Figure 2e , 7d, S5c, and S5d, the authors should add western blot data for cells treated with lysosomal inhibitors such as Chloroquine or Bafilomycin A1. Figure 3 , the authors should investigate if endogenous Parkin is upregulated in cells depleting Fis1 and overexpressing STX17. If so, Parkin/Fis1 DKO cells should be tested to promote STX17-mediated mitophagy.
In
3. In Figure 4 , the authors should perform co-IP assays to examine STX17 ∆CT-Fis1 and STX17 ∆NT-ATG14 interactions.
4. In Figure 5 , the authors should test whether mitochondrial targeting of ATG14 in Fis1 KO cells depends on overexpression of STX17. Figure 8 , the authors should analyze STX17-ATG14 interaction by co-IP and mitochondrial targeting of STX17 and ATG14 by subcellular fractionation for cells grown in galactose medium.
Reviewer #3 (Remarks to the Author):
In the manuscript, Xian et al., showed that Fis1, one of mitochondrial outer membrane fission protein, is able to interact with STX17,and depletion of Fis1 induced mitophagy that is dependent on STX17, but not on Parkin translocation. They further showed that knockout of Fis1 can induce STX translocated on MAM, where it interacts with ATG14 which further recruits core autophagy proteins hierarchically to form mitophagosomes, followed by Rab7-dependent mitophagosome-lysosome fusion. While the results are interesting, much of the work relied on the overexpressing of particular genes and some of the images are not of high quality. The mitophagy assay is mainly based on the colocalization of autophagy gene products on mitochondria. More comprehensive analysis of biochemical hallmarks and by mt-Keima are required. Previous studies has already shown that high level of Fis1 promotes mitophagy, and these literatures need to be discussed in the discussion. Specifics 1. There are reports showing Parkin independent pathway of mitophagy. For example, PINK1 directly interact with autophagy receptors such as OPTN, NDP52. Also, mitophagy receptors such as NIX, FUNDC1, PHB2 and others have been reported to mediated Parkin independent mitophagy. The authors may be interested to check if these receptors are involved.
2. In Figure 1 , the authors showed that FIS1 interacts with STX17 when overexpressed. It is important to check if the endogenous FIS1 interacts with STX17 upon FCCP or Hypoxia stress. It would be better to have quantitative analysis of Figure 1e , 1f. Biochemical analysis of mitochondrial proteins in the outer membrane, inner membrane and mitochondrial matrix in addition to LC3 and p62 is needed. Same to Figure 2 and other figures 4. Figure 2a , it may be better to display key data such as Fis KD conditions and put quantitative analysis of other KO conditions. In Figure 2d , I do not see the expression of GFP signals location for STX17; 5. Figure 2F , EM images are of poor quality. Only GFP-STX17/FIS1 KO samples have autophasomal structures?
6. it would be interesting to check the localization of endogenous STX17 and Rab7 with FIS KO or FCCP stress?
We are deeply thankful for the invaluable perspectives and constructive suggestions from the three reviewers to improve our manuscript. As requested, we have performed the following additional suggested experiments, as described in details below.
Reviewers' comments:
Reviewer #1 (Remarks to the Author):
In this manuscript, the authors identified that Fis1 interacts with STX17. Then, they found that overexpression of STX17 in Fis1 KO/KD cells induce mitophagy. They further studied the specific domain required for Fis1-STX17 interaction and the role of the domains on mitophagy. As previously reported, they showed that STX17 interacts with Atg14 and localizes on MAM. As expected again, they showed that most of conventional autophagy factors are related with STX17 induced mitophagy in Fis1KO cells. Although there shown large number of experimental results in this paper, each experiments are not well performed to confirm their conclusion. Especially, the observation of mitophagy is not well performed.
Most importantly, overexpression of STX17 in Fis1 KO/KD is not physiological situation.
This reviewer thinks that the mitophagy induction used in this paper is too artificial and it is not reflects phenomena in vivo.
A: We appreciate this reviewer's perspectives and thank the reviewer for pointing out these key issues. Firstly, to elaborate more comprehensive observations of mitophagy, we have extensively strengthened our notion of mitophagy, through conducting mt-Keima assay and examining the turnover of mitochondrial proteins (including OMM, IMS, IMM and matrix proteins), and validated the dramatic rescue effect using the lysosomal inhibitor chloroquine. These new data are now included in Fig 2e, 2g, 2h , S2d, S3d, 6f, 6i and 7d of our revised manuscript.
Secondly, in light of STX17 overexpression, we share the same concern with the reviewer. Nevertheless, to clarify this issue more clearly, here below we also list three lines of evidence to support our study and humbly hope for your consent. (1) To accomplish the reviewer's first advice in using alternative method to validate mitophagy, we have newly generated WT and Fis1 KO HeLa cells stably expressing mtKeima. As suggested, we have provided new data to further validate mitophagy, approached with confocal imaging of mt-Keima marker (Fig 2g) . Determined by the ratio of acidified mt-Keima per cell by FACS, as a quantitative indicator of mitophagy, we observed that Fis1 deficiency resulted in a significant higher proportion of mito-lysosome in GFP-STX17 expressing cells from 7.37±2.34% to 56.88±2.24% (Fig 2h and S3d) . Our data clearly demonstrate that STX17 initiates mitophagy upon Fis1 loss.
(2) As requested by the reviewer, we have also examined the co-localization between mitochondria (Tim23) and autophagosome (LC3) in STX17-mediated mitophagy (Fig R1   as attached below) . Notably, Bafilomycin A1 is well-known to inhibit the fusion of Fig 3a, last panel) . Parkin was not observed to co-localize with mitochondria even in Fis1 KO and Flag-STX17 overexpressed cells, despite striking mitochondria clearance was appreciated. In addition, our quantitative analysis using more than 150 cells further validates that STX17-mediated mitophagy upon Fis1 loss is not related to Parkin recruitment (Fig 3b) . (Fig S7c-e) , suggesting that isolation membrane proteins ATG5 and ATG14 modulate the puncta formation of GFP-STX17. To further address the sequential step between STX17 puncta formation and isolation membrane formation, we devoted efforts in live cell imaging, to determine the initiation of mitophagy in Fis1 KO cells ( Fig   R3 as attached below) . Of note, as early as 6 h of post-transfection by GFP-ATG14 (to label isolation membrane) and mCherry-STX17 (to indicate STX17 puncta), STX17 puncta was observed to form and isolation membrane was initiated by Fis1 loss. In addition, given the close relationship between ATG14 and STX17, in the cases whereby STX17 was observed to form puncta in Fis1 KO cells, ATG14 aggregated as puncta, colocalized with STX17 perfectly. These lines of evidence essentially reached the notion that, to discriminate the sequence between STX17 puncta and isolation membrane initiation would be difficult, and complementarily, STX17 itself could be a crucial part for isolation membrane as well. Taken together, our data reached the conclusion that isolation membrane is crucial for STX17 puncta formation and vice versa. and GFP-ATG14 (green) for 6 h. Live cells were imaged. Scale bar, 10 µm.
Page 11 line14, (Fig. Sc-e) should be (Fig. S5c-e) .
A: We are very sorry for this error and thank the reviewer very much for reminding.
Given more data included in our revised manuscript, we have re-organized the figures and it has been amended accordingly.
Page 12 line 8, "TBC1D15, the GTPase protein for Rab7" should be "TBC1D15, the GTPase-activating protein for Rab7."
A: We apologize for this mistake and appreciate the reviewer for kindly pointing out. Yes, we have amended the phrase as "TBC1D15, the GTPase-activating protein for Rab7" (page 13).
Reviewer #2 (Remarks to the Author):

In this manuscript, Xian et al. report the role of Syntaxin 17 (STX17), an ER/mitochondriaassociated membrane (MAM)-localized SNARE family protein, in mitochondria-specific autophagy (mitophagy). Recent studies establish that STX17 regulates autophagy and mitochondrial fission in mammalian cells, however, whether it also functions in mitophagy
has not been explored. In this study, the authors initially focused on Fis1, an evolutionarily conserved mitochondrial outer membrane protein that has been suggested to act in mitochondrial dynamics and mitophagy, and identified STX17 as a Fis1-interacting protein. Fig 8e) . In addition, robust decreases of GFP-STX17 and ATG14 in MAM/mitochondrial fractions were detected upon galactose culturing (Fig 8f-h) . Taken together, these results both clearly reached complementation to our conclusion that galactose suppresses STX17-medaited mitophagy (Fig 8c-d) Fig R4a (as attached below) , we found no appreciable effect of FCCP or hypoxia on the endogenous interaction between STX17 and Fis1 (indicated by red arrowhead, lower band than the non-specific band shown by cyan asterisk). Unfortunately, we need to point out that the solely available commercial STX17 antibody is produced in rabbit, whereas the rabbit-Fis1 antibody is more efficient for Co-IP, compared with the mouse-Fis1 antibody (Fig R4b as attached below) . In this case, after Co-IP, the immunoblotting analysis of STX17 (Fig R4a, around 37 kDa) would easily cross-talk with the heavy chain band (around 55kDa) and the light chain band (around 25kDa) of rabbit Fis1, all recognized by the anti-rabbit secondary antibody. On the other hand, endogenous STX17 level is rather low (which could not be recognized by the STX17 antibody from immunofluorescent analysis, shown in Fig R5 below) , supporting that the endogenous interaction between Fis1 and STX17 might be very difficult to detect. (Fig S2b-c) . We depleted Fis1 by RNA interference in HeLa cells stably expressing GFP-STX17, and further validated this conclusion by treating cells with lysosomal inhibitor chloroquine (CQ) (Fig S2d) . We humbly hope these new data may clarify your doubts. Fig S3b) . However, as we are focusing on mitochondria, we apologize that we did not include macroautophagosome structures here.
Strikingly, overexpression of STX17 in cells depleting
Figure 2a
it would be interesting to check the localization of endogenous STX17 and Rab7 with FIS KO or FCCP stress?
A: We deeply appreciate these kind advices from this reviewer.
Regarding the endogenous STX17, we apologize that we failed to find a suitable commercial antibody for immunostaining analysis (Fig R5 appended as below 
